Last reviewed · How we verify
combination of TLC D-99 and Ifosfamide — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
combination of TLC D-99 and Ifosfamide (combination of TLC D-99 and Ifosfamide) — Istituto Clinico Humanitas.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| combination of TLC D-99 and Ifosfamide TARGET | combination of TLC D-99 and Ifosfamide | Istituto Clinico Humanitas | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- combination of TLC D-99 and Ifosfamide CI watch — RSS
- combination of TLC D-99 and Ifosfamide CI watch — Atom
- combination of TLC D-99 and Ifosfamide CI watch — JSON
- combination of TLC D-99 and Ifosfamide alone — RSS
Cite this brief
Drug Landscape (2026). combination of TLC D-99 and Ifosfamide — Competitive Intelligence Brief. https://druglandscape.com/ci/combination-of-tlc-d-99-and-ifosfamide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab